Rituximab for Ocular Inflammatory Disease

Ocul Immunol Inflamm. 2022 Aug;30(6):1300-1302. doi: 10.1080/09273948.2022.2141034.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Eye*
  • Humans
  • Immunologic Factors* / therapeutic use
  • Rituximab / therapeutic use

Substances

  • Rituximab
  • Immunologic Factors